One-year clinical outcome after ablation with a novel multipolar irrigated ablation catheter for treatment of atrial fibrillation: potential implications for clinical use.

Publication

One-year clinical outcome after ablation with a novel multipolar irrigated ablation catheter for treatment of atrial fibrillation: potential implications for clinical use.

Journal Paper/Review - Jan 11, 2016

Wakili Reza, Siebermair Johannes, Fichtner Stephanie, Sinner Moritz F, Klocker Eva, Olesch Lucia, Hilberath Jan N, Sarai Samira, Clauss Sebastian, Sattler Stefan, Kääb Stefan, Estner Heidi L

Citation

Wakili R, Siebermair J, Fichtner S, Sinner M, Klocker E, Olesch L, Hilberath J, Sarai S, Clauss S, Sattler S, Kääb S, Estner H. One-year clinical outcome after ablation with a novel multipolar irrigated ablation catheter for treatment of atrial fibrillation: potential implications for clinical use. Europace 2016; 18:1170-8.

Type

Journal Paper/Review (English)

Journal

Europace 2016; 18

Publication Date

Jan 11, 2016

Issn Electronic

1532-2092

Pages

1170-8

Brief description/objective

Pulmonary vein isolation (PVI) is an established therapy for atrial fibrillation (AF). However, PVI remains a time-consuming procedure. A novel multipolar irrigated radiofrequency (RF) ablation catheter (nMARQ™) is aiming to improve PVI. We investigated the influence on procedural parameters and assessed clinical outcomes after PVI using this novel catheter.